Not sure Zip, but I think the FDA sets up their evaluation of generic drugs based solely on bioavailability of the active ingredient and possibly not the condition of the ingredient, i.e. whether it is oxidized or not. We think that is rather important but most of the medical community has not seized the importance of that.